Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Coca-Cola Amatil was a leading beverage manufacturer and distributor in the Asia-Pacific region, serving as one of the largest anchor bottlers for The Coca-Cola Company globally. Headquartered in Australia, the company managed a diverse portfolio of sparkling drinks, water, sports and energy drinks, fruit juices, and coffee across markets including Australia, New Zealand, Indonesia, Papua New Guinea, Fiji, and Samoa. In May 2021, the company was acquired by Coca-Cola European Partners to form Coca-Cola Europacific Partners (CCEP), creating one of the world's largest consumer goods companies. Its operations included extensive manufacturing facilities and a massive distribution network throughout its geographic footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Coca-Cola Amatil.